Impedimed Ltd has released a press release.
Appendix 4C - Quarter Ended 30 June 2016
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Impedimed
- IPD and Mayo Clinic Sign Joint Development Agreement
- Relationship with Redox to Expand EHR Integration Capability
- Vanderbilt to Begin Testing Next Generation Device
- Medicare Proposes New Reimbursement Rates, L-Dex Increases
- Five Year Multi-Location Clinical Trial with Mayo Clinic
Later from Impedimed
- Scripps to use SOZO in Heart Failure Study
- SOZO Launched - First Product for Health and Wellness Market
- Appendix 4E and Press Release
- Study on Efficacy of L-Dex in Routine Clinical Practice
- Appendix 4C - Quarter Ended 30 September 2016
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed